Skip to main navigation Skip to search Skip to main content

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: Results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study

K. A. Papp*, R. Kaufmann, D. Thaçi, C. Hu, D. Sutherland, P. Rohane

*Corresponding author for this work
106   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: Results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science